The Future of

Bio/Pharmaceutical Analysis

Online Summit 2024

Now On-Demand

Speakers

20 June

Speakers

Tim Sandle

Dr Tim Sandle

Head of QA GxP Compliance

Bio Products Laboratory

Bio Products Laboratory logo

Dr Tim Sandle has over 25 years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and has authored 30 books on microbiology, healthcare and pharmaceutical sciences.

Tim works for Bio Products Laboratory Limited (BPL) in the UK and is a visiting tutor at both the University of Manchester and UCL.

Lonza logo
Panel

2.15 – 3.15 pm CET

Endotoxin testing:

The future of recombinant methods

With an ever-increasing focus on sustainability across the pharmaceutical industry, many companies are looking to recombinant methods for bacterial endotoxin testing. During this panel discussion, experts will discuss the latest guidelines and regional variations on recombinant Factor C (rFC) and recombinant Cascade Reagents (rCR). Make sure you join to:

  • Stay up to date with landscape surrounding the use of rFC and rCR
  • Learn about different approaches and strategies for method validation
  • Evaluate different technologies that can support your BET needs
Allen Burgenson with Lonza logo

Allen Burgenson

SME Testing Services
Lonza

Phil Duncanson with AstraZeneca logo

Phil Duncanson

Chief Microbiologist, Global Quality
AstraZeneca

Ingo Spreitzer with Paul-Ehrlich-Institut logo

Ingo Spreitzer

Deputy Head Microbiology Safety Section
Paul-Ehrlich-Institut

Radhakrishna Tirumalai with Merck logo

Radha Tirumalai

Senior Principal Scientist
Merck Research Laboratories

Tim Sandle with Bio Products Laboratory logo

Moderator: Dr Tim Sandle

Head of QA GxP Compliance and Sterility Assurance
Bio Products Laboratory